In a major decision, the central government has now banned the manufacture and sale of oxytocin by the private sector.
The decision also includes banning of the import of the oxytocin with immediate effect.
The move comes after several reports about the misuse of the hormone in agriculture and the dairy industry.
Oxytocin in any form or name will not be allowed to be sold through retail Chemist.
There are also elaborate regulations that have been laid down for the manufacture and supply of oxytocin for use in hospitals. It is now said that the manufacturers will supply directly to hospitals.
These regulations will come into effect from July 1. Among the harmful effects of unwarranted exposure to oxytocin are early puberty and nausea.
The matter was considered by the Drugs Technical Advisory Board, a statutory body constituted under the Drugs and Cosmetics Act, 1940.
The Board recommended that Oxytocin formulations for human use be regulated and restricted to be supplied only to registered hospitals and clinics in public and private sector to prevent its misuse.>